(Q24241582)

https://api.crossref.org/works/10.1002%2F14651858.CD007204.PUB2

The therapeutic potential of cannabis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007204.PUB2

Atypical antipsychotics for aggression and psychosis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007204.PUB2

Cholinesterase inhibitors for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007204.PUB2

Alzheimer's disease; taking the edge off with cannabinoids?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007204.PUB2

Bias in treatment assignment in controlled clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007204.PUB2

A description of agitation in a nursing home

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007204.PUB2

Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007204.PUB2

A molecular link between the active component of marijuana and Alzheimer's disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007204.PUB2

The therapeutic potential of the cannabinoids in neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007204.PUB2

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007204.PUB2

Donepezil for the treatment of agitation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007204.PUB2

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007204.PUB2

Observed affect in nursing home residents with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007204.PUB2

Alzheimer's disease in the UK: comparative evidence on cost of illness and volume of health services research funding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007204.PUB2

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007204.PUB2

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007204.PUB2

Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007204.PUB2

Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007204.PUB2

Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007204.PUB2

Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007204.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007204.PUB2

Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007204.PUB2

Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007204.PUB2

Identification and functional characterization of brainstem cannabinoid CB2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007204.PUB2

Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19370677

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The impact of dementia on the family

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19370677

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19370677